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Abstract
Aim: We aimed to explore the utility of the Multiple Array Probe Leiden
(MAPLe) device to assess pelvic floor muscle activity in men with lower urinary
tract symptoms (LUTS).
Methods: This was an observational cohort study performed at the urology
outpatient department of a large teaching hospital in the Netherlands between
April and October 2018. We recruited male patients referred for the assessment
of LUTS, without a history of prostate surgery, if they had an International
Prostate Symptom Score greater than or equal to 8. The MAPLe device was then
used to assess the puborectalis, pubococcygeus, iliococcygeus, urogenital
diaphragm, and the internal and external anal sphincters during three tasks:
a rest period (1 minute), five maximum voluntary contractions (held for
3 seconds each), and three maximal endurance contractions (held for
15 seconds each).
Results: In total, 57 patients were included, 5 of which had diabetes mellitus.
Muscle activity at rest was significantly lower than during either contraction
task and did not differ between the muscle groups. By contrast, the external anal
sphincter had significantly less activity than any other muscle group during the
endurance task, and the internal anal sphincter and puborectalis had
significantly less activity during the maximum voluntary contraction task. No
association was found between pelvic floor muscle activity and LUTS severity
during any task.
Conclusion: Pelvic floor muscle activity and LUTS severity appear to be
unrelated, but this does not completely exclude the possibility of muscle
involvement in the development or experience of symptoms. Further research is
needed.
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1 | INTRODUCTION
The potential role of pelvic floor muscle function in lower
urinary tract symptoms (LUTS) has not been studied
thoroughly among men, contrasting starkly with the
situation in women.1,2 This can, at least in part, be
explained by difficulties when assessing the male pelvic
floor.3 In a small study using real‐time magnetic
resonance imaging in healthy male volunteers,4
functional changes were shown in the pelvic floor before
and during micturition. Before voiding, it was noted that
there was relaxation of the pelvic floor and widening of
the angle between the pubic bone and the ventral
prostate. One participant who was unable to void did
not have these features.4 Practical difficulties in the
assessment of pelvic floor muscle activity may be
overcome using the Multiple Array Probe Leiden
(MAPLe) device, an anal probe with a matrix of
24 electrodes capable of registering electromyography
(EMG) signals.5 When placed correctly, the electrodes
match to individual pelvic floor muscles. To date,
however, validation studies of the MAPLe device have
only included healthy subjects, and we are aware of no
studies in males with LUTS.
We aimed to explore pelvic floor muscle activity with
the MAPLe device in men with LUTS of varying
severities.
2 | MATERIALS AND METHODS
2.1 | Study design, setting, and
participants
This observational cohort study was conducted at the
urology outpatient department of a large teaching
hospital in the Netherlands between April and October
2018. We included adult male patients (age≥ 18 years)
referred for the assessment of moderate to severe LUTS
with no complications, such as recurrent urinary tract
infections or previous prostate surgery for benign or
malignant conditions. We excluded patients with poor
command of the Dutch language or a history of cancer
and/or surgery of the prostate or bladder. The relevant
medical ethics committee approved this study (number
171205).
2.2 | Data collection
All men provided written informed consent. LUTS
severity was assessed by the International Prostate
Symptom Score (IPSS),6 and the Overactive Bladder
Symptom Score (OABSS).7 Uroflowmetry was performed
using an MMS FlowMaster, and was considered repre-
sentative if the voided volume was greater than or equal
to 125mL.8 The post‐void residual was measured by
abdominal ultrasound of the urinary bladder. Transrectal
ultrasound was not routinely used.
Directly following the urologist’s appointment,
researchers performed a final eligibility check to assess
symptom severity, excluding those with an IPSS smaller
than or equal to 7, and performed an additional
assessment of the pelvic floor muscles using the MAPLe
device. At this stage, participants were asked to view an
instructional video about correct probe placement. The
probe was inserted by patients under the supervision
of a researcher, who then checked whether the final
placement was satisfactory. This was defined as a correct
orientation of the probe, to ensure that the sides of the
probe equalled the front, back, left, and right. For this,
the direction of the attached cables is important. The
shape of the MAPLe device, with a notch at the base of
the probe, around which the anal sphincter closes,
further supports adequate placement.
The MAPLe device is a probe with a matrix of 24
electrodes (six levels, 10 mm apart, on the four different
sides of the probe), with which EMG signals can be
measured from the different layers and sides of the pelvic
floor muscles. In a validation study, Voorham‐van der
Zalm et al demonstrated with static and dynamic
magnetic resonance imaging that placement of the
electrodes with respect to the different pelvic floor
muscles was accurate.5
Performance on three tasks was assessed using the
MAPLe device in the supine position: (a) rest (one period
for 1 minute); (b) maximum voluntary contractions (five
held for 3 seconds each); and (c) maximal endurance
contractions (three held for 15 seconds each). The
instruction given on how to activate the pelvic floor
muscles was “try to hold back bowel movements, passing
flatus or gas.” Subjects were allowed short rest periods of
5 seconds between each maximum voluntary contraction
and 10 seconds between each maximal endurance con-
traction. Measurements were repeated if the researcher
observed co‐contraction of the muscles of the abdominal
wall or upper legs and/or the absence of an inward
movement of the perineum. If the probe was expelled, the
researcher manually supported it while the participant
repeated the task.
2.3 | Data handling
A visual representation of pelvic floor muscle activity is
presented in a tablet application developed for the
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MAPLe device. Gray scales (from black to white)
represent the microvolt readings for the 24 electrodes,
which are graphically presented in a “bull’s eye” pattern.
After performing the three tasks, a mean microvolt value
for each task was calculated by the software and
displayed as a summary statistic. For the analyses in this
study, however, raw data were needed from each
electrode. Novuqare, the developer of the MAPLe device,
provided support in retrieving these data. For this, they
required us to send an anonymised backup file of the
MAPLe application, which was returned as raw data. We
could then use those data to calculate the mean microvolt
values for all 24 electrodes and all tasks. Subsequently,
the readings from electrodes corresponding to specific
pelvic floor muscles could be combined based on an
established method.5,9 This resulted in mean microvolt
values that represented the m.puborectalis (PR; electro-
des 3 and 4 on the left, right, and backside of the probe),
m.pubococcygeus and m.iliococcygeus (PIC; electrodes 1
and 2, left, right, and backside), the urogenital diaphragm
(UD, electrodes 1 to 5, front side of the probe), the
internal anal sphincter (IAS; electrode 5, all side of the
probe), and the external anal sphincter (EAS; electrode 6,
all side of the probe). Present insights show that the UDF
differs from other pelvic floor muscles and consists
mainly of membranous and fascial tissues, and should be
considered as a functional structure which is crossed by
the urethra.
2.4 | Statistical analysis
Patient characteristics are presented as means and
standard deviations or as medians and interquartile
ranges (IQRs), depending on the data distributions. To
explore the differences in pelvic floor muscle activity by
muscle group, we presented the outcomes for each
muscle per task. Friedman’s test was then used to assess
the difference in the median microvolt result between
each muscle and task, separately. A post hoc Wilcoxon
signed‐rank test was used to identify differences between
pelvic floor muscles or groups. To explore the possible
association between symptom severity and pelvic floor
muscle activity, we applied Spearman’s correlation
coefficients for the outcomes of the MAPLe measurement
with the OABSS and IPSS. Outcomes were then
presented for each of the five muscle groups per task.
Finally, we compared the outcomes between men with
and without diabetes mellitus, by means of presenting
median values and P values for the Spearman correlation
coefficient. Because our analyses resulted in multiple
comparisons, we applied the Bonferroni adjustment. We
considered P≤ .005 to be statistically significant in all
analyses. IBM SPSS, version 25 (IBM Corp, Armonk, NY)
was used for all statistical analyses.
3 | RESULTS
We included 57 patients in the study, and their
characteristics are summarized in Table 1. The partici-
pants had a mean age of 67.1 ± 10 years, a mean IPSS of
19.2 ± 6.2, and a mean OABSS of 6.1 ± 3.2. Five men were
diagnosed with diabetes mellitus.
During the 1‐minute rest task, pelvic floor muscle
activity was as follows: 4.4 μV in the PR, 4.4 μV in the
PIC, 4.9 μV in the UDF, 5.0 μV in the IAS, and 4.2 μV in
the EAS. Differences between these muscle groups were
not significant (Figure 1A). Therefore, in the analysis of
pelvic floor muscle activity and symptoms, the five
muscle groups were combined for the 1‐minute rest task.
During the maximum voluntary contractions task, the
EAS showed significantly lower activity (13.2 μV) than
either the IAS (17.3 μV) or the PR (16.8 μV) by the
Wilcoxon signed‐rank test. EAS activity also did not differ
significantly between the UDF and the PIC (Figure 1B).
During the endurance task, the EAS (11.9 μV) showed
significantly lower activity than the other muscle groups
(PR 15.7 μV, IAS 16.0 μV, PIC 16.4 μV, and UD 15.2 μV;
Figure 1C).
When comparing the three tasks by muscle group, a
clear difference was seen between the rest activity and
both the maximum voluntary contraction and endurance
tasks. However, the differences between the maximum
voluntary contraction tasks and endurance tasks were not
significant for any muscle group (Figure 2).
TABLE 1 Patient characteristics (N = 57)
Characteristics N (%) Mean± SD
Age, y 67.1 ± 10.4
BMI, kg/m2 27.2 ± 3.4
Uroflowmetry (Qmax) 9.4 ± 5.2
Post‐void residual 80.6 ± 111.2
Voiding diary, 24 h
Maximum voided volume, mL 324 ± 149
Frequency, times/24 h 11 ± 4
Nocturia, times/24 h 2 ± 2
IPSS (0‐35) 19.2 ± 6.2
Mild (0‐7) 0 (0)
Moderate (8‐19) 32 (56)
Severe (20‐35) 25 (44)
OABSS (0‐15) 6.1 ± 3.2
Mild (≤5) 22 (39)
Moderate (6‐11) 33 (58)
Severe (≥12) 2 (3)
Abbreviations: BMI, body mass index; IPSS, International Prostate Symptom
Score; OABSS, Overactive Bladder Symptom Score.
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No association was found between pelvic floor muscle
activity and LUTS severity on any of the three tasks
(Table 2). The strongest correlations were found for the
IPSS with the IAS (0.19), the PIC (0.18), and the UDF
(0.21), but none of these had significant P values.
The five men with diabetes were shown to have higher
activity of PR, IAS, PIC, and UD in all measurements
(Table 3), but differences did not reach the predefined
threshold of statistical significance (P< .005).
4 | DISCUSSION
We used the MAPLe device to explore the activity of
pelvic floor muscles, together with how that activity was
associated with symptom severity, in a symptomatic
cohort of men, without a history of prostate surgery.
Although no association was found despite the large
cohort, there remains sufficient reason to consider that
our findings do not exclude the possible role of pelvic
FIGURE 1 A, Median microvolt with
interquartile range for each muscle group
at rest, (B) MVC, and (C) endurance.
P values reflect the results from the
Wilcoxon signed‐ranks test between each
muscle group. EAS, external anal
sphincter; IAS, internal anal sphincter;
MVC, maximum voluntary contraction;
PFM, pelvic floor muscle; PIC,
pubococcygeus and iliococcygeus; PR,
puborectalis; UDF, urogenital diaphragm
FIGURE 2 A‐E, Median microvolt with interquartile range for each of the three tasks (rest, MVC, and endurance) within each muscle
group. P values reflect the results from the Wilcoxon signed‐ranks test between each task. EAS, external anal sphincter; IAS, internal anal
sphincter; PFM, pelvic floor muscle; PIC, pubococcygeus and iliococcygeus; PR, puborectalis; UDF, urogenital diaphragm
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floor muscles in LUTS. Indeed, several issues may
explain our failure to show an association.
First, we only performed measurements in a sympto-
matic population, and we did not include an asympto-
matic control group. We, therefore, have no normal
values against which to compare pelvic floor muscle
activity. This is compounded by the fact that the MAPLe
device is relatively new and has no large studies. Second,
we did not identify subgroups with bladder outlet
obstruction, under‐ or overactive bladder, and dysfunc-
tional voiding. Identifying subgroups rather than includ-
ing all men with LUTS may reveal important differences
in muscle activity. Third, measurements were performed
in a resting state and not during the voiding phase or the
end of the storage phase when patients with LUTS most
often report symptoms. Measuring pelvic floor muscle
activity during a pressure‐flow study or during uroflow-
metry may facilitate the evaluation of the pelvic floor
during voiding and storage phases.
This study still provides valuable insights into the
possible merits of assessing pelvic floor muscle activity
with the MAPLe device, despite failing to show a clear
association between symptom severity and muscle
activity. During the 1‐minute rest task, activity did not
differ significantly between the five muscle groups, yet
during the maximum voluntary contraction task, EAS
activity was significantly lower than that of either the IAS
or PR. This lower activity could be explained by the EAS
containing both slow‐ and fast‐twitch fibers that are
subject to fatigue. By contrast, the IAS is an involuntary
muscle that follows as a continuation of the inner
gastrointestinal wall, and as such, contains smooth
slow‐wave fibers that may be less prone to fatigue.10
Given that patients contracted five times for 3 seconds
each during the maximum voluntary contractions,
exhaustion might have led to less muscle activity in the
EAS than in the IAS.
The higher muscle tone in the PR during maximum
voluntary contractions could be explained by the
instruction given to “hold back bowel movements,
passing flatus or gas” during the assessment, which
possibly required a lifting action by the PR and less
activation of the EAS. Compared with the other muscle
groups, which each had similar activities, the EAS also
showed significantly less activity during the endurance
task. In addition, poor differentiation between the pelvic
floor muscles could have resulted from electromagnetic
interference between probe signals or from certain
muscles having the same distribution. However, we
could not easily correct these issues.
Higher activity was shown in the small subgroup of
diabetics (n = 5), compared with men without diabetes.
As this group was very small and no additional
information is known about the duration of the disease,
current treatment, and possible complications, it is
difficult to explain this outcome in more detail.
In our study, pelvic floor muscle activity was lower for all
five muscle groups across all three tasks compared with the
results from a study in a healthy cohort of younger
participants.5 The effect of fatigue was reduced in our study
by asking participants to perform five rather than ten
maximum voluntary contractions and by asking them to
TABLE 2 Association (Spearman’s correlation) between pelvic
floor muscle activity and symptoms (IPSS/OABSS) during rest,
MVC, and endurance
Measurement Muscle group IPSS OABSS
Rest Combined 0.08 −0.07










Note: All values for P> .005.
Abbreviations: EAS, external anal sphincter; IAS, internal anal sphincter;
IPSS, International Prostate Symptom Score; MVC, maximum voluntary
contraction; OABSS, Overactive Bladder Symptom Score; PIC, pubococcygeus
and iliococcygeus; PR, puborectalis; UDF, urogenital diaphragm.
TABLE 3 Median pelvic floor muscle activity for men with and




(n = 52) P value*
Rest
PR 5.60 4.20 .077
EAS 5.68 3.85 .140
IAS 7.55 4.37 .018
PIC 6.95 4.30 .016
UDF 7.32 4.66 .045
MVC
PR 27.98 16.47 .044
EAS 15.79 13.24 .521
IAS 26.98 16.94 .018
PIC 32.30 17.21 .031
UDF 24.34 15.91 .015
Endurance
PR 15.39 15.67 .521
EAS 11.78 12.11 .000
IAS 20.87 15.71 .036
PIC 20.20 15.24 .314
UDF 19.91 15.16 .357
Abbreviations: EAS, external anal sphincter; IAS, internal anal sphincter;
MVC, maximum voluntary contraction; PIC, pubococcygeus and
iliococcygeus; PR, puborectalis; UDF, urogenital diaphragm.
*P value for Spearman’s correlation coefficient.
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perform the three maximal endurance contractions over
15 seconds rather than 30 seconds. An explanation for
the lower muscle activity in our study might be that the
thickness of the EAS decreases in men as they age.11 The
mean age of men in the present study was 67 years,
compared with 41 years in the earlier study.5 In younger and
healthier men, the EAS retains optimal function and
thickness that should allow for greater pelvic floor muscle
activation.
Future studies must now focus on confirming the
normal values for pelvic floor muscle activity, using the
MAPLe device. This should include consideration of
patient subgroups with different pelvic floor problems
and should seek to establish clinically relevant thresholds
for abnormality. It would also be interesting to monitor
muscle activity during voiding or at the end of the storage
phase across all ages in healthy and symptomatic men.
This would allow us to evaluate the association of LUTS
with pelvic floor dysfunction in greater detail.
5 | CONCLUSION
We are aware of no other research exploring pelvic floor
muscle activity in a large group of men with LUTS. Using the
MAPLe device, it was possible to differentiate between five
muscles or muscle groups in the pelvic floor, but we did not
show an association between symptom severity and the
activity of those muscles. However, despite our mixed results,
we believe that there is sufficient evidence to assert that the
presence of an association between pelvic floor muscle
activity and LUTS cannot be excluded. Further research is
therefore warranted, so we are conducting follow‐up
research not only to compare pelvic floor muscle activity
between males with and without LUTS but also to assess
pelvic floor muscle activity during voiding.
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